Synthesis of PAF-acether and blood volume changes in gram-negative sepsis
- 28 February 1985
- journal article
- Published by Elsevier in Immunopharmacology
- Vol. 9 (1) , 45-52
- https://doi.org/10.1016/0162-3109(85)90046-3
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin.Journal of Clinical Investigation, 1983
- Reciprocal antimicrobial synergism between Escherichia coli and Bacteroides fragilis in the presence of metronidazole.Journal of Clinical Pathology, 1982
- Platelet-activating factor (PAF-acether) and macrophagesCellular Immunology, 1981
- Novel effects of 1-0-hexadecyl-2-acyl-sn-glycero-3-phosphorylcholine mediators on human leukocyte function: Delineation of the specific roles of the acyl substituentsBiochemical and Biophysical Research Communications, 1980
- Elevated Thromboxane Levels in the Rat during Endotoxic ShockJournal of Clinical Investigation, 1980
- Physical and chemical properties of platelet-activating factor obtained from human neutrophils and monocytes and rabbit neutrophils and basophilsBiochimica et Biophysica Acta (BBA) - General Subjects, 1980
- Antihypertensive activity of an alkyl ether analog of phosphatidylcholineBiochemical and Biophysical Research Communications, 1979
- Structural analysis of purified platelet-activating factor by lipasesNature, 1977
- Increased Sheep Lung Vascular Permeability Caused by Pseudomonas BacteremiaJournal of Clinical Investigation, 1974
- LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETSThe Journal of Experimental Medicine, 1972